We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Kidney Transplant Patients at Higher Risk of CV Events

By HospiMedica International staff writers
Posted on 23 Feb 2017
Renal transplant recipients (RTRs) are often admitted with acute myocardial infarction (AMI), according to a new study.

Researchers at St. More...
Luke's University Health Network conducted a study to examine trends in AMI admissions for 9,243 RTRs with functioning grafts. The data were then compared to those of 160,932 patients with end-stage renal disease without transplantation (ESRD-NRT) and 5,640,851 patients without advanced kidney disease (non-ESRD/RT) admitted with AMI. Treatment strategies appeared largely unchanged during the course of the study, with the exception of an increase in primary percutaneous coronary intervention (PCI) among RTRs admitted with ST-segment elevation myocardial infarction (STEMI).

The results showed that 0.2% of AMI admissions were RTRs, with STEMI accounting for 29.3% of the total admissions. Trend analysis showed that in-hospital mortality among RTR admitted for non-STEMI decreased from 3.8% to 2.1% between 2003 and 3011, whereas the mortality rates for STEMI RTR patients remained unchanged. When compared with non-ESRD/RT, history of renal transplantation was independently associated with a decreased likelihood of STEMI at presentation. The study was published on February 15, 2017, in The American Journal of Cardiology.

“In conclusion, RTR were frequently admitted with AMI, particularly non-STEMI, and were found to have multiple coronary artery disease risk factors despite their younger age,” concluded lead author Sahil Agrawal, MD, and colleagues of the department of cardiology. “Compared with other forms of renal replacement therapy, renal transplant was associated with lower inhospital mortality.”

Cardiovascular disease is the leading cause of death in dialysis patients, and the most common cause of death and allograft loss among RTRs. ESRD is associated with an increased incidence and prevalence of a wide range of CVDs including coronary artery disease, stroke, congestive heart failure, atrial fibrillation, sudden cardiac death, pulmonary hypertension, and valvular heart disease. CVD risk factors are very common in patients with ESRD, and most patients have multiple risk factors.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.